1Menendez R,Amor AM,Rodeiro I,et al.Policosanol modulates HMG-CoA reductase activity in cultured fibroblasts.Arch Med Res,2001,32(1):8-12.
2Arruzazabala ML,Valdes S,Mas R,et al.Effect of policosanol successive dose increases on platelet aggregation in healthy volunteers.Pharmacol Res,1996,34(5-6):181-185.
3Arruzazabala ML,Valdes S,Mas R,et al.Comparative study of policosanol,aspirin and the combination therapy policosanol-aspirin on platelet aggregation in healthy volunteers.Pharmacol Res,1997,36(4):293-297.
4Noa M,de la Rosa MC,Mas R.Effect of policosanol on foam-cell formation in carrageenan-induced granulomas in rats.J Pharm Pharmacol,1996,48(3):306-309.
5Menendez R,Mas R,Amor AM,et al.Effects of policosanol treatment on the susceptibility of low density lipoprotein (LDL) isolated from healthy volunteers to oxidative modification in vitro.Br J Clin Pharmacol,2000,50(3):255-262.
6Noa M,Mas R,Mesa R.Effect of policosanol on intimal thickening in rabbit cuffed carotid artery.Int J Cardiol,1998,67(2):125-132.
7Mas R,Castano G,Fernandez J,et al.Long-term effects of policosanol on obese patients with type Ⅱ hypercholesterolemia.Asia Pac J Clin Nutr,2004,13(Suppl):S102.
8Mirkin A,Mas R,Martinto M,et al.Efficacy and tolerability of policosanol in hypercholesterolemic postmenopausal women.Int J Clin Pharmacol Res,2001,21 (1):31-41.
9Pons P,Rodriguez M,Robaina C,et al.Effects of successive dose increases of policosanol on the lipid profile of patients with type Ⅱ hypercholesterolemia and tolerability to treatment.Int J Clin Pharmacol Res,1994,14(1):27-33.
10Castano G,Mas R,Fernandez L,et al.Effects of policosanol 20 versus 40 mg/day in the treatment of patients with type Ⅱ hypercholesterolemia:a 6-month double-blind study.Int J Clin Pharmacol Res,2001,21 (1):43-57.